Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

Yu Ichi Noto, Kazumoto Shibuya, Yasunori Sato, Kazuaki Kanai, Sonoko Misawa, Setsu Sawai, Masahiro Mori, Tomoyuki Uchiyama, Sagiri Isose, Saiko Nasu, Yukari Sekiguchi, Yumi Fujimaki, Takashi Kasai, Takahiko Tokuda, Masanori Nakagawa, Satoshi Kuwabara

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

TAR DNA binding protein of 43 kDa (TDP-43) is likely to be the major pathogenetic protein in amyotrophic lateral sclerosis (ALS). A previous study has shown that levels of TDP-43 in CSF measured by an ELISA are significantly higher for ALS patients than for controls. The aim of this study was to investigate whether elevated CSF TDP-43 levels are specific to ALS, and are associated with clinical profiles in ALS patients. We measured CSF TDP-43 levels by the same ELISA in 27 ALS patients and 50 neurodegenerative or inflammatory disease controls such as Parkinson's disease, multiple sclerosis, and Guillain-Barré syndrome. Results showed that the CSF TDP-43 levels were increased only in ALS patients. Receiver operating characteristic (ROC) analyses showed a sensitivity of 59.3% and a specificity of 96.0%. We also found that lower CSF TDP-43 levels may be associated with shorter survival time. In conclusion, the CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS. Moreover, among ALS patients, lower levels of CSF TDP-43 may reflect the accumulation of TDP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.

Original languageEnglish
Pages (from-to)140-143
Number of pages4
JournalAmyotrophic Lateral Sclerosis
Volume12
Issue number2
DOIs
Publication statusPublished - 2011 Mar 1
Externally publishedYes

Fingerprint

Amyotrophic Lateral Sclerosis
Sensitivity and Specificity
Enzyme-Linked Immunosorbent Assay
Survival
DNA-Binding Proteins
Motor Neurons
ROC Curve
Multiple Sclerosis
Parkinson Disease
Biomarkers
Prospective Studies

Keywords

  • Amyotrophic lateral sclerosis
  • cerebrospinal fluid (CSF)
  • ELISA
  • TAR DNA binding protein of 43 kDa (TDP-43)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis : Specificity, sensitivity, and a possible prognostic value. / Noto, Yu Ichi; Shibuya, Kazumoto; Sato, Yasunori; Kanai, Kazuaki; Misawa, Sonoko; Sawai, Setsu; Mori, Masahiro; Uchiyama, Tomoyuki; Isose, Sagiri; Nasu, Saiko; Sekiguchi, Yukari; Fujimaki, Yumi; Kasai, Takashi; Tokuda, Takahiko; Nakagawa, Masanori; Kuwabara, Satoshi.

In: Amyotrophic Lateral Sclerosis, Vol. 12, No. 2, 01.03.2011, p. 140-143.

Research output: Contribution to journalArticle

Noto, YI, Shibuya, K, Sato, Y, Kanai, K, Misawa, S, Sawai, S, Mori, M, Uchiyama, T, Isose, S, Nasu, S, Sekiguchi, Y, Fujimaki, Y, Kasai, T, Tokuda, T, Nakagawa, M & Kuwabara, S 2011, 'Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value', Amyotrophic Lateral Sclerosis, vol. 12, no. 2, pp. 140-143. https://doi.org/10.3109/17482968.2010.541263
Noto, Yu Ichi ; Shibuya, Kazumoto ; Sato, Yasunori ; Kanai, Kazuaki ; Misawa, Sonoko ; Sawai, Setsu ; Mori, Masahiro ; Uchiyama, Tomoyuki ; Isose, Sagiri ; Nasu, Saiko ; Sekiguchi, Yukari ; Fujimaki, Yumi ; Kasai, Takashi ; Tokuda, Takahiko ; Nakagawa, Masanori ; Kuwabara, Satoshi. / Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis : Specificity, sensitivity, and a possible prognostic value. In: Amyotrophic Lateral Sclerosis. 2011 ; Vol. 12, No. 2. pp. 140-143.
@article{0e8280075eea47b083afd70a82cef0fe,
title = "Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value",
abstract = "TAR DNA binding protein of 43 kDa (TDP-43) is likely to be the major pathogenetic protein in amyotrophic lateral sclerosis (ALS). A previous study has shown that levels of TDP-43 in CSF measured by an ELISA are significantly higher for ALS patients than for controls. The aim of this study was to investigate whether elevated CSF TDP-43 levels are specific to ALS, and are associated with clinical profiles in ALS patients. We measured CSF TDP-43 levels by the same ELISA in 27 ALS patients and 50 neurodegenerative or inflammatory disease controls such as Parkinson's disease, multiple sclerosis, and Guillain-Barr{\'e} syndrome. Results showed that the CSF TDP-43 levels were increased only in ALS patients. Receiver operating characteristic (ROC) analyses showed a sensitivity of 59.3{\%} and a specificity of 96.0{\%}. We also found that lower CSF TDP-43 levels may be associated with shorter survival time. In conclusion, the CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS. Moreover, among ALS patients, lower levels of CSF TDP-43 may reflect the accumulation of TDP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.",
keywords = "Amyotrophic lateral sclerosis, cerebrospinal fluid (CSF), ELISA, TAR DNA binding protein of 43 kDa (TDP-43)",
author = "Noto, {Yu Ichi} and Kazumoto Shibuya and Yasunori Sato and Kazuaki Kanai and Sonoko Misawa and Setsu Sawai and Masahiro Mori and Tomoyuki Uchiyama and Sagiri Isose and Saiko Nasu and Yukari Sekiguchi and Yumi Fujimaki and Takashi Kasai and Takahiko Tokuda and Masanori Nakagawa and Satoshi Kuwabara",
year = "2011",
month = "3",
day = "1",
doi = "10.3109/17482968.2010.541263",
language = "English",
volume = "12",
pages = "140--143",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis

T2 - Specificity, sensitivity, and a possible prognostic value

AU - Noto, Yu Ichi

AU - Shibuya, Kazumoto

AU - Sato, Yasunori

AU - Kanai, Kazuaki

AU - Misawa, Sonoko

AU - Sawai, Setsu

AU - Mori, Masahiro

AU - Uchiyama, Tomoyuki

AU - Isose, Sagiri

AU - Nasu, Saiko

AU - Sekiguchi, Yukari

AU - Fujimaki, Yumi

AU - Kasai, Takashi

AU - Tokuda, Takahiko

AU - Nakagawa, Masanori

AU - Kuwabara, Satoshi

PY - 2011/3/1

Y1 - 2011/3/1

N2 - TAR DNA binding protein of 43 kDa (TDP-43) is likely to be the major pathogenetic protein in amyotrophic lateral sclerosis (ALS). A previous study has shown that levels of TDP-43 in CSF measured by an ELISA are significantly higher for ALS patients than for controls. The aim of this study was to investigate whether elevated CSF TDP-43 levels are specific to ALS, and are associated with clinical profiles in ALS patients. We measured CSF TDP-43 levels by the same ELISA in 27 ALS patients and 50 neurodegenerative or inflammatory disease controls such as Parkinson's disease, multiple sclerosis, and Guillain-Barré syndrome. Results showed that the CSF TDP-43 levels were increased only in ALS patients. Receiver operating characteristic (ROC) analyses showed a sensitivity of 59.3% and a specificity of 96.0%. We also found that lower CSF TDP-43 levels may be associated with shorter survival time. In conclusion, the CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS. Moreover, among ALS patients, lower levels of CSF TDP-43 may reflect the accumulation of TDP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.

AB - TAR DNA binding protein of 43 kDa (TDP-43) is likely to be the major pathogenetic protein in amyotrophic lateral sclerosis (ALS). A previous study has shown that levels of TDP-43 in CSF measured by an ELISA are significantly higher for ALS patients than for controls. The aim of this study was to investigate whether elevated CSF TDP-43 levels are specific to ALS, and are associated with clinical profiles in ALS patients. We measured CSF TDP-43 levels by the same ELISA in 27 ALS patients and 50 neurodegenerative or inflammatory disease controls such as Parkinson's disease, multiple sclerosis, and Guillain-Barré syndrome. Results showed that the CSF TDP-43 levels were increased only in ALS patients. Receiver operating characteristic (ROC) analyses showed a sensitivity of 59.3% and a specificity of 96.0%. We also found that lower CSF TDP-43 levels may be associated with shorter survival time. In conclusion, the CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS. Moreover, among ALS patients, lower levels of CSF TDP-43 may reflect the accumulation of TDP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.

KW - Amyotrophic lateral sclerosis

KW - cerebrospinal fluid (CSF)

KW - ELISA

KW - TAR DNA binding protein of 43 kDa (TDP-43)

UR - http://www.scopus.com/inward/record.url?scp=79951764734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951764734&partnerID=8YFLogxK

U2 - 10.3109/17482968.2010.541263

DO - 10.3109/17482968.2010.541263

M3 - Article

C2 - 21126161

AN - SCOPUS:79951764734

VL - 12

SP - 140

EP - 143

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 2

ER -